Sections View Full Chapter Figures Tables Videos Annotate Full Chapter Figures Tables Videos Supplementary Content +++ APPENDIX B: ANSWERS TO EXERCISES +++ CHAPTER 2 ++ This is a retrospective cohort or case–control study because the study leverages data from an historical data source and includes both case and control groups. This is an observational longitudinal study that is best categorized as a cohort study. The cohort here is newly diagnosed cancer patients. This study design is interesting, and some might be tempted to call it case–control. The purpose was to compare self-reported therapy with actual therapy. Both of these measures (self-reported and actual) occurred at the same time, so the study also has some characteristics of a cross-sectional study. Our opinion is that the study is case–control, but it illustrates the difficulty in classifying studies cleanly into any scheme. The study is observational and is a matched case–control study. The study is a placebo-controlled randomized clinical trial. The group of subjects was identified and initial data collection occurred in 1976; the same subjects were followed up in future years. The study design is, therefore, best described as a cohort or prospective study to identify risk factors. Several study designs are possible, but the most realistic is an observational study. A case–control study provides information faster, but several case–control studies are required; a group of cases for each cause of death and type of cardiovascular morbidity needs to be identified. We suggest you use one of the electronic search programs to see if you can locate a copy of a cohort study, and, if so, read and discuss the pros and cons of how the study was done. +++ CHAPTER 3 ++ The sum of the deviations (22.26, 3.36, 15.46, 6.96, … −7.84, −17.04, −0.14) is zero. Using the Numerical Summary in R Commander or the Descriptives program in SPSS, the mean SF-12 Total Score for the 1,132 subjects was 58.0 with a standard deviation of 24.8. See Table B–1. See Figure B–1. Table Graphic Jump Location|Download (.pdf)|Print SF12_total_score age_cat N Mean Median Std. Deviation Minimum Maximum ≤60 223 61.31 67.08 24.82 5.42 97.92 61–70 366 62.76 67.29 24.25 3.33 100.00 71–80 358 56.09 55.21 24.58 5.00 100.00 >80 182 47.89 42.82 22.95 3.75 94.17 Total 1129 57.96 59.17 24.79 3.33 100.00 Age was available for 1,129 patients. The mean age must be estimated using the weighted means formula. It is found by multiplying the midpoint of each age interval by the count: [(223×55.5)+(366×65.5)+(358×75.5) +(182×85.5)]/1129=69.92 The mean SF-12 Total Score is estimated by multiplying the count by the mean in each age group: [(223×61.31)+(366×62.76)+(358×56.09) +(182×47... Your Access profile is currently affiliated with [InstitutionA] and is in the process of switching affiliations to [InstitutionB]. Please select how you would like to proceed. Keep the current affiliation with [InstitutionA] and continue with the Access profile sign in process Switch affiliation to [InstitutionB] and continue with the Access profile sign in process Get Free Access Through Your Institution Learn how to see if your library subscribes to McGraw Hill Medical products. Subscribe: Institutional or Individual Sign In Error: Incorrect UserName or Password Username Error: Please enter User Name Password Error: Please enter Password Sign in Forgot Password? Forgot Username? Download the Access App: iOS | Android Sign in via OpenAthens Sign in via Shibboleth You already have access! Please proceed to your institution's subscription. Create a free profile for additional features.